World chess champion Garry Kasparov made headlines all over the world in 1997 for something that he probably wasn’t very excited about. He lost a chess match. To a computer. It was an IBM supercomputer called Deep Blue and its victory in that New York City match marked the first time a reigning world chess champion had been defeated by a computer under tournament conditions. It was also a symbolically significant event, the first sign that artificial intelligence could become equal to or even
Read More
Guardant Health
Top 60 Health IT/Digital Health Mergers & Acquisitions in 2019
- From Google's acquisition of Fitbit to Philips acquisition of Carestream Health's health IT business, here is a look at some of the biggest health IT/digital health mergers & acquisitions in 2019 by each quarter. Q1 M&A Activity Johnson & Johnson Acquires Auris Health for $3.4B to Expand Digital Surgery Portfolio Johnson & Johnson acquiresAuris Health, a developer of robotic technologies for $3.4 billion in cash. Auris Health is a privately-held developer of
Read More
March 2019 News, Merger & Acquisition, IPO, Public Company Performance Summary
A brief summary of noteworthy news, health IT M&A activity, IPOs, and public company performance during the month of March. Noteworthy News Amazon, JP Morgan, Berkshire Names New Joint Venture Haven Amazon, J.P. Morgan, and Berkshire Hathaway name joint venture Haven. In January 2018, the three founding companies announced plans to create this independent organization, now called Haven, which is free from profit-making incentives and constraints. Haven’s focus is the 1.2 million
Read More
Guardant Health to Acquire Cancer Diagnostic Company Bellwether Bio
Precision oncology company Guardant Health, Inc., announced that it has entered into a definitive agreement to acquire Seattle-based Bellwether Bio, an oncology startup developing next generation cancer diagnostics using cell-free DNA. The acquisition is expected to close in April 2019. Financial terms of the acquisition were not disclosed. Bellwether Bio Background Spun out of the University of Washington in 2016, Bellwether Bio (formerly known as Haverhill Genetics) is developing
Read More
Guardant Health Nabs $100M for Biopsy-Free Cancer Genomic Testing
Guardant Health, a Redwood City, CA-based company revolutionizing cancer detection through biopsy-free tumor sequencing has raised $100M in Series D funding led by healthcare-investment firm OrbiMed. Existing Guardant Health investors Khosla Ventures, Sequoia Capital, Lightspeed Venture Partners, Pejman Mar, Formation 8, Heritage Group, and others also participated in the funding round. Founded in 2012 by a team of serial entrepreneurs with expertise in next-generation sequencing, single-cell
Read More
